Project Grant W911SR261A001
Award Date 12/1/25
Completion Date 11/30/28
Dollars Obligated $104K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
- This $1,161,428 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated, multimodal, and multiplexed ferrobotic system for point-of-care pathogenic and serological tick-borne disease diagnosis. The award, granted to the University of California, Los Angeles (UCLA), aims to advance biomedical research and transform healthcare for military service members, veterans, and the general public....
- This $324,493.13 Project Grant awarded by the Defense Health Agency on February 21, 2025 supports research and development of novel repellent textiles that can provide protection from disease vectors for the U.S. Army. The funded work, which is part of the Department of Defense's Pest Management and Vector Control Research program (CFDA 12.355), will further advance Anovoteks' technology for creating repellent fabrics for Army combat uniforms and modular lightweight load-carrying equipment....
- The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
- This federal Project Grant award from the Defense Health Agency, under the Pest Management and Vector Control Research program (CFDA 12.355), provides $267,319.71 to Drexel University to develop 2D materials for protection against mosquito-borne disease. The research aims to create new interventions to protect deployed military personnel from arthropod-borne diseases and improve vector control technologies. The funding will support a 3-year effort, starting on January 12, 2026, with a final...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,729,963.00 to the University of California, Davis (UC Davis) to develop novel therapeutics targeting BET-mediated oncogenesis in lethal prostate cancer. The award period runs from November 1, 2025 to October 31, 2028. As a prominent public research university, UC Davis has extensive capabilities in conducting sophisticated biomedical research and...
- The University of California, Davis was awarded a $483,000 Project Grant from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING DRUG-TOLERANT PERSISTER CELLS IN OVARIAN CANCER." The award period is from April 1, 2024 to March 31, 2026. The objective of this research project is to develop new treatments for ovarian cancer by targeting drug-tolerant persister cells. As a major public research university, UC...
- This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
- The University of California, Davis was awarded a $321,981 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on April 1, 2025. The grant will fund research to investigate the sensory processing contributions to emotion dysregulation and internalizing problems in individuals with autism. The project aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $644,000.00 to the University of California, Davis (UC Davis) to support research on a PLZ4-targeting ultra-small DM1 nanoconjugate for bladder cancer therapy. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative diagnostic tools, therapeutic interventions, and clinical...
- The Department of Defense's Defense Health Agency awarded a $1,330,054 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of California, San Francisco (UCSF). The grant supports the "CLINICAL VALIDATION AND IMPLEMENTATION OF A HOST-PATHOGEN-BASED DIAGNOSTIC ASSAY FOR EARLY LYME DISEASE AND OTHER TICK-BORNE INFECTIONS" project, with a performance period from July 1, 2024 to June 30, 2027. As a leading academic medical...